反応式
[N:1]1([C:7]2[C:8]3[O:15][C:14]4[CH:16]=[CH:17][CH:18]=[CH:19][C:13]=4[C:9]=3[N:10]=[CH:11][N:12]=2)[CH2:6][CH2:5][NH:4][CH2:3][CH2:2]1.N1C=CC=CC=1.[Cl-].[N:27]1[CH:32]=[CH:31][CH:30]=[N:29][C:28]=1[NH:33][S:34]([C:37]1[CH:42]=[CH:41][C:40]([NH:43][CH:44]=[S:45])=[CH:39][CH:38]=1)(=[O:36])=[O:35].CO>ClCCl>[N:27]1[CH:32]=[CH:31][CH:30]=[N:29][C:28]=1[NH:33][S:34]([C:37]1[CH:42]=[CH:41][C:40]([NH:43][C:44]([N:4]2[CH2:5][CH2:6][N:1]([C:7]3[C:8]4[O:15][C:14]5[CH:16]=[CH:17][CH:18]=[CH:19][C:13]=5[C:9]=4[N:10]=[CH:11][N:12]=3)[CH2:2][CH2:3]2)=[S:45])=[CH:39][CH:38]=1)(=[O:36])=[O:35]参加物
6
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
To a solution of 4-piperazinobenzofurano[3,2-d]pyrimidine (200 mg, 0.79 mmol) and pyridine (0.5 mL, 7.9 mmol) in dichloromethane (20 mL) was added a solution of product 1d in dichloromethane (20 mL) and this was stirred overnight. Methanol was added to quench excess thiophosgene; and the residue after removal of solvent was purified by silica gel column chromatography eluting with 5% methanol/dichloromethane and further recrystallized from dichloromethane/hexane to give 150 mg (37%).
後処理
- customto quench excess thiophosgene
- customand the residue after removal of solvent
- customwas purified by silica gel column chromatography
- washeluting with 5% methanol/dichloromethane
- customfurther recrystallized from dichloromethane/hexane
- customto give 150 mg (37%)
出典と根拠
- ORDレコード
- ord-f51360050cf5415db699fdca2bd05cdb
- 出典データセット
- uspto-grants-2015_04
- 特許番号
- US08999988B2
関連ノート
読み込み中…